We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ZYPREXA IntraMuscular Olanzapine 10 mg Powder for Solution for Injection Vial (Hong Kong)
Section 19A approved medicine
ZYPREXA IntraMuscular Olanzapine 10 mg Powder for Solution for Injection Vial (Hong Kong)
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Current
Medicines in short supply/unavailable
ZYPREXA IM olanzapine 10mg powder for injection vial
ARTG - 76867
ARTG - 76867
Indication(s)
Indicated for the rapid control of agitation and disturbed behaviours in patients with schizophrenia and related psychoses and in patients with acute mania associated with Bipolar 1 Disorder, when oral therapy is not appropriate.
Images
